XML 38 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statement of Cash Flows - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2015
Dec. 31, 2014
Cash flow from operating activities      
Net loss $ (3,833) $ (29,672) $ (16,317)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation expense   4,027 425
Depreciation   600 184
Amortization of premiums and discounts on marketable securities   452  
Change in fair value of preferred stock tranche liability   9,750 1,949
Non-cash interest on convertible promissory notes payable 67   2
Expense related to shares issued in connection with services performed     250
Deferred rent   277 (342)
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets   (234) (1,185)
Other non-current assets (14) 14 (7)
Deferred revenue   54,982  
Accounts payable 950 (942) 604
Accrued expenses 105 2,788 537
Other non-current liabiliites   (189) 186
Lease incentive benefit     1,112
Net cash provided by (used in) operating activities (2,725) 41,299 (11,918)
Cash flow from investing activities      
Purchases of property and equipment   (1,030) (2,988)
Change in restricted cash     (314)
Purchases of marketable securities   (220,399)  
Proceeds from marketable securities   26,660  
Net cash used in investing activities   (194,769) (3,302)
Cash flow from financing activities      
Proceeds from issuance of Series A redeemable convertible preferred stock and tranche rights, net of issuance costs 2,860 19,999 22,040
Proceeds from issuance of Series B redeemable convertible preferred stock, net of discount and issuance costs   84,780  
Proceeds from issuance of common stock and restricted stock   10 80
Conversion of preferred stock to common stock   72,955  
Net cash provided by financing activities 2,860 177,744 22,120
Net increase in cash and cash equivalents 135 24,274 6,900
Cash and cash equivalents, beginning of period   7,035 135
Cash and cash equivalents, end of period $ 135 31,309 7,035
Supplemental Disclosure of Cash and non-cash Activities      
Accretion of redeemable convertible preferred stock to redemption value   7,373 1,366
Exchange of promissory notes payable and accrued interest into Series A redeemable convertible preferred stock and tranche rights   $ 150,187 $ 2,929